Becker Continued Access Study
NCT01286870 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 11
Last updated 2019-03-06
Summary
While Core Becker patient follow-up is being completed this Continued Access Study is designed to enroll patients at a limited rate per month to allow for continued physician and patient experience with the device.
Up to 12 patients per month at sites across the United States will be enrolled in this research study. These patients will be implanted with the Becker 25 or Becker 50 Expander/Breast implant and monitored for 10 years for safety.
Conditions
- Breast Reconstruction
Interventions
- DEVICE
-
Mentor Becker 25 Expander/Breast Implant
The breast implant is comprised of the Becker implant and the injection dome/fill tube and has a low bleed, gel-filled outer lumen and an adjustable saline-fillable inner lumen. The inner lumen can be gradually filled with saline over an extended period of time via the fill tube by injecting saline through the injection dome. Once expanded to the desired volume, the fill tube and injection dome are removed through a small incision under local anesthetic, and the prosthesis remains in position as a breast implant. The Becker 25 Expander/Breast Implant has a silicone gel volume of approximately 25% and saline volume of approximately 75%. The Becker Expander/Breast Implant is available in sizes 150 - 800cc.
- DEVICE
-
Mentor Becker 50 Expander/Breast Implant
The breast implant is comprised of the Becker implant and the injection dome/fill tube and has a low bleed, gel-filled outer lumen and an adjustable saline-fillable inner lumen. The inner lumen can be gradually filled with saline over an extended period of time via the fill tube by injecting saline through the injection dome. Once expanded to the desired volume, the fill tube and injection dome are removed through a small incision under local anesthetic, and the prosthesis remains in position as a breast implant. The Becker 50 Expander/Breast Implant has a 50% gel volume and a 50% saline volume, so a 400cc implant would nominally have 200cc of saline and 200cc of silicone. The Becker 50 Expander/Breast Implant is available in sizes from 300 to 700cc.
Sponsors & Collaborators
-
Mentor Worldwide, LLC
lead INDUSTRY
Principal Investigators
-
Mark A. Walker · Binghamton, NY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-06-01
- Primary Completion
- 2014-03-04
- Completion
- 2014-03-04
Countries
- United States
Study Locations
More Related Trials
-
Evaluate Retention of an Orally Administered Device Using Gamma Scintigraphy
NCT00754091 ·Status: COMPLETED ·Phase: PHASE1
-
A 5 Year Clinical Investigation on Creos Xenoprotect
NCT02373787 ·Status: TERMINATED ·Phase: NA
-
Evaluate Retention of an Orally Administered Device Using Gamma Scintigraphy Study 2
NCT00780286 ·Status: COMPLETED ·Phase: PHASE1
-
Gen 2 Battrode Wear Study
NCT07256951 ·Status: RECRUITING ·Phase: NA
-
Confirming Feeding Tube Position Using CORTRAK
NCT04601571 ·Status: WITHDRAWN ·Phase: NA
-
Clinical Evaluation of the Zynex Blood Volume Monitor (CM-1500) in Healthy Male Adult Subjects During a Blood Draw
NCT01646060 ·Status: COMPLETED ·Phase: PHASE1
-
Minimally-Invasive Realtime Assessment of Continuous Lactate in Exercise
NCT04238611 ·Status: UNKNOWN ·Phase: NA
-
US Post-Market Surveillance Study of the Surfacer System
NCT05050799 ·Status: RECRUITING
-
Effectiveness Study of the BOA(R)-Constricting IV Band
NCT01104103 ·Status: TERMINATED ·Phase: NA
-
Investigational On-body Injector Clinical Study
NCT05553418 ·Status: COMPLETED ·Phase: NA
-
BodyGuardian Respiration and Activity Validation Testing
NCT02255526 ·Status: COMPLETED
-
Transcutaneous Bilirubinometry in Neonates With Bilicare System
NCT02372058 ·Status: COMPLETED ·Phase: NA
-
Study to Demonstrate the Efficacy and Safety of Convatec ConvaFoam™ Silicone, ConvaFoam™ Border and ConvaFoam™ Non-adhesive Dressings to Protect Against Skin Breakdown
NCT05902182 ·Status: UNKNOWN ·Phase: NA
-
WP02 Continued Access Study
NCT04862156 ·Status: TERMINATED ·Phase: NA
-
A First-in-human Trial to Assess the Safety and Performance of the BioCaptis in Healthy Volunteers
NCT05813041 ·Status: UNKNOWN ·Phase: NA
-
Clinical Evaluation of the Zynex Monitoring System, Model CM-1600
NCT05740644 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study Focusing on Fit of Made-to-measure Compression Garments in Healthy Subjects II
NCT04714476 ·Status: COMPLETED ·Phase: NA
-
Novel Cervical Retraction Device
NCT02283463 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Volunteers During a Blood Draw
NCT01834612 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Biocompatibility of Cartridge Blood Set Versus Standard Blood Line
NCT00804453 ·Status: COMPLETED ·Phase: NA
-
Neck-Worn Monitoring Sensor for - A Study for Monitoring Subjects With Fluid-Management Issues During Dialysis
NCT02140905 ·Status: COMPLETED
-
Prospective Clinical Evaluation of BD NRFit™ Devices and Accessories.
NCT05953363 ·Status: COMPLETED
-
Novel Guidance Device for Image Fusion and Needle Guidance in Lung, Liver or Kidney Biopsy
NCT04039529 ·Status: WITHDRAWN ·Phase: NA
-
Wound Imaging Study to Gather Clinical References for a Device to Assist Selecting Level-of-amputation in PAD Patients
NCT03611361 ·Status: TERMINATED
-
Normothermic Liver Preservation Trial
NCT03089840 ·Status: COMPLETED ·Phase: PHASE1/PHASE2